Target intelligence / Profile preview

Immunoglobulin heavy variable 1 orphon 15-2 pseudogene (IGHV1OR15-2)

Target
IGHV1OR15-2
Molecular classification
Pseudogene, Immunoglobulin gene family, Orphon (gene not on main IGH locus)
01

Overview

IGHV1OR15-2 is a pseudogene located on chromosome 15, part of the immunoglobulin heavy variable family. It shares high sequence similarity with functional immunoglobulin variable genes (such as IGHV1-2), but lacks protein-coding capacity due to genetic divergence and loss-of-function mutations. Its transcription may be detected in some tissues, and upregulation is observed in certain malignancies (such as nasopharyngeal carcinoma), presumably as non-coding RNA with potential regulatory effects, rather than via protein function. IGH orphons refer to immunoglobulin genes located outside the main locus on chromosome 14; these typically do not produce functional antibody variable regions. There is no evidence IGHV1OR15-2 encodes a cell surface receptor, enzyme, or any tractable pharmacological target. Its biological and clinical significance is limited to research on non-coding RNAs and pseudogene expression. If you are seeking a molecule for therapeutic targeting, IGHV1OR15-2 is not suitable. Its standard gene annotation in major genomic databases (HGNC, Ensembl, GenBank) is “pseudogene” and it is not included in curated drug target databases[3][4][5].

Other names
IGHV1OR15-2IGHV1OR15Immunoglobulin heavy variable 1 orphon 15-2LOC100287128
02

Mechanism of action

Not applicable.

03

Biological functions

No known protein-coding biological function (as a pseudogene)
04

Disease associations

IGHV1OR15-2 and similar pseudogenes have been studied for differential expression in cancer (e.g., upregulated in nasopharyngeal carcinoma); possible indirect roles in tumor biology via non-coding RNA, but these are speculative and not targetable by drugs
05

Safety considerations

None documented; pseudogenes do not encode active protein products.
06

Interacting drugs

None — as a pseudogene it does not encode a protein target for drugs.
07

Biomarkers

Not established as a clinical biomarker; research context only, e.g., as a differentially expressed pseudogene in cancer studies

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1 orphon 15-2 pseudogene (IGHV1OR15-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1 orphon 15-2 pseudogene (IGHV1OR15-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call